We are live on ! Find out more
CFM

Capricorn Fund Managers Portfolio holdings

AUM $1.27B
1-Year Est. Return 70.17%
This Fund
S&P 500
This Quarter Est. Return
+29.44%
1 Year Est. Return
+70.17%
3 Year Est. Return
+169.21%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$415M
AUM Growth
+$117M
Cap. Flow
+$84.1M
Cap. Flow %
20.26%
Top 10 Hldgs %
35.96%
Holding
106
New
47
Increased
17
Reduced
15
Closed
24

Top Buys

Rank Stock Value
1
ZYME icon
Zymeworks
ZYME
+$22.3M
2
GPCR icon
Structure Therapeutics
GPCR
+$10.3M
3
BLFS icon
BioLife Solutions
BLFS
+$9.91M
4
NUVB icon
Nuvation Bio
NUVB
+$9.84M
5
ALAB icon
Astera Labs
ALAB
+$8.36M

Top Sells

Rank Stock Value
1
TARS icon
Tarsus Pharmaceuticals
TARS
+$16.3M
2
VERA icon
Vera Therapeutics
VERA
+$13.1M
3
PHR icon
Phreesia
PHR
+$11.4M
4
IONS icon
Ionis Pharmaceuticals
IONS
+$10.7M
5
REAL icon
The RealReal
REAL
+$10.4M

Sector Composition

Rank Sector Weight
1 Healthcare 44.36%
2 Technology 15.14%
3 Industrials 8.91%
4 Communication Services 8.61%
5 Consumer Discretionary 8.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KVYO icon
76
Klaviyo
KVYO
$5.72B
$649K 0.16%
+20,000
New +$560K
BETA
77
Beta Technologies Inc
BETA
$5.07B
$564K 0.14%
+20,000
New +$597K
BORR
78
Borr Drilling
BORR
$1.21B
$443K 0.11%
+110,000
New +$365K
TGNA
79
DELISTED
TEGNA Inc
TGNA
$241K 0.06%
+12,435
New +$246K
ASC icon
80
Ardmore Shipping
ASC
$712M
$148K 0.04%
+14,000
New +$166K
TALO icon
81
Talos Energy
TALO
$2.38B
$138K 0.03%
+12,500
New +$131K
HEPS
82
D-Market Electronic Services & Trading
HEPS
$1.05B
$72.4K 0.02%
29,185
– –
ABBV icon
83
AbbVie
ABBV
$433B
– –
-29,535
Closed -$6.84M
ADT icon
84
ADT
ADT
$5.76B
– –
-125,000
Closed -$1.09M
AKRO
85
DELISTED
Akero Therapeutics
AKRO
– –
-149,200
Closed -$7.08M
BTI icon
86
British American Tobacco
BTI
$128B
– –
-65,000
Closed -$3.45M
COCO icon
87
Vita Coco
COCO
$3.67B
– –
-65,515
Closed -$2.78M
CPRI icon
88
Capri Holdings
CPRI
$1.88B
– –
-50,000
Closed -$996K
DECK icon
89
Deckers Outdoor
DECK
$13.6B
– –
-25,000
Closed -$2.53M
DOCS icon
90
Doximity
DOCS
$3.95B
– –
-76,738
Closed -$5.61M
FIVE icon
91
Five Below
FIVE
$12B
– –
-16,000
Closed -$2.48M
IONS icon
92
Ionis Pharmaceuticals
IONS
$9.06B
– –
-162,800
Closed -$10.7M
JNJ icon
93
Johnson & Johnson
JNJ
$613B
– –
-36,760
Closed -$6.82M
LEVI icon
94
Levi Strauss
LEVI
$9.48B
– –
-50,000
Closed -$1.17M
NKE icon
95
Nike
NKE
$61.6B
– –
-45,920
Closed -$3.2M
ONON icon
96
On Holding
ONON
$12.6B
– –
-50,000
Closed -$2.12M
PHR icon
97
Phreesia
PHR
$698M
– –
-484,500
Closed -$11.4M
RBLX icon
98
Roblox
RBLX
$26.4B
– –
-19,605
Closed -$2.72M
RL icon
99
Ralph Lauren
RL
$22.6B
– –
-10,000
Closed -$3.14M
SMMT icon
100
Summit Therapeutics
SMMT
$10.4B
– –
-496,266
Closed -$10.3M
1 2 3
4
5

Similar funds

TC
Teilinger Capital Houston, Texas $1.27B AUM 5.87% 1-Year Est. Return
EIA
Edgemoor Investment Advisors Bethesda, Maryland $1.27B AUM 25.83% 1-Year Est. Return
CAM
Cozad Asset Management Champaign, Illinois $1.27B AUM 31.6% 1-Year Est. Return
FBCM
Fort Baker Capital Management Larkspur, California $1.27B AUM 25.46% 1-Year Est. Return
NCM
Novare Capital Management Charlotte, North Carolina $1.26B AUM 20.28% 1-Year Est. Return
TWP
Triad Wealth Partners Lawrence, Kansas $1.26B AUM 17.86% 1-Year Est. Return
TBC
Tweedy, Browne Co Stamford, Connecticut $1.26B AUM 33.88% 1-Year Est. Return
HP
Harvey Partners Tarrytown, New York $1.26B AUM 64.44% 1-Year Est. Return

Capricorn Fund Managers's Q4 2025 Portfolio in Review

As of Q4 2025, Capricorn Fund Managers held 106 positions worth $415M, up 39% from $298M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Capricorn Fund Managers deployed $84.1M of net new capital in Q4 2025, opening 47 new positions and adding to 17 existing holdings. Its largest new stake was Zymeworks: 1,022,840 shares worth $26.9M.

By sector, the portfolio is most concentrated in Healthcare at 44% of assets, up from 41% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Tarsus Pharmaceuticals, an estimated $16.3M trimmed.

  • Capricorn Fund Managers's largest Q4 2025 buy was Zymeworks: 1,022,840 shares worth $26.9M.
  • Capricorn Fund Managers added most to Waystar Holding Corp in Q4 2025, an estimated $8.31M increase.
  • Capricorn Fund Managers's biggest Q4 2025 reduction was Tarsus Pharmaceuticals, cutting an estimated $16.3M.
  • Capricorn Fund Managers fully exited Vera Therapeutics in Q4 2025, selling an estimated $13.1M.
  • Capricorn Fund Managers's ten largest holdings make up 36% of its $415M portfolio in Q4 2025.
  • Capricorn Fund Managers opened 47 new positions and closed 24 in Q4 2025.
  • Capricorn Fund Managers's portfolio value rose 39% quarter-over-quarter to $415M.

Based on Capricorn Fund Managers's 13F filing for Q4 2025, filed 21 Jan 2026.